...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Top-Line Primary Endpoint Results for Phase 3 BETonMACE Cardio Outcomes Trial were Announced September 30th ****Detailed Trial Data to be Presented at AHA Late Breaking Session Nov 16th & Company Webcast Nov 18th******

Message: Booyah ! I told you all!!

 "Please stop and be objective"

Lol. The irony. Objectivity is based on facts, which many of your claims, EagleEyeCap, of late are completely devoid of. 


New Message
Please login to post a reply